Correlation Between Bank of America and BioMark Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and BioMark Diagnostics, you can compare the effects of market volatilities on Bank of America and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and BioMark Diagnostics.

Diversification Opportunities for Bank of America and BioMark Diagnostics

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bank and BioMark is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Bank of America i.e., Bank of America and BioMark Diagnostics go up and down completely randomly.

Pair Corralation between Bank of America and BioMark Diagnostics

Considering the 90-day investment horizon Bank of America is expected to generate 0.55 times more return on investment than BioMark Diagnostics. However, Bank of America is 1.83 times less risky than BioMark Diagnostics. It trades about 0.15 of its potential returns per unit of risk. BioMark Diagnostics is currently generating about -0.16 per unit of risk. If you would invest  4,168  in Bank of America on September 13, 2024 and sell it today you would earn a total of  440.00  from holding Bank of America or generate 10.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy97.73%
ValuesDaily Returns

Bank of America  vs.  BioMark Diagnostics

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Bank of America and BioMark Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and BioMark Diagnostics

The main advantage of trading using opposite Bank of America and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.
The idea behind Bank of America and BioMark Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data